RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Rosa A. Maldonado to Leishmania major

This is a "connection" page, showing publications Rosa A. Maldonado has written about Leishmania major.
Connection Strength

3.043
  1. Rodriguez F, Iniguez E, Pena Contreras G, Ahmed H, Costa TEMM, Skouta R, Maldonado RA. Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major. Molecules. 2018 07 04; 23(7).
    View in: PubMed
    Score: 0.659
  2. Iniguez E, Schocker NS, Subramaniam K, Portillo S, Montoya AL, Al-Salem WS, Torres CL, Rodriguez F, Moreira OC, Acosta-Serrano A, Michael K, Almeida IC, Maldonado RA. An a-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major. PLoS Negl Trop Dis. 2017 Oct; 11(10):e0006039.
    View in: PubMed
    Score: 0.628
  3. Vasquez MA, Iniguez E, Das U, Beverley SM, Herrera LJ, Dimmock JR, Maldonado RA. Evaluation of a,?-unsaturated ketones as antileishmanial agents. Antimicrob Agents Chemother. 2015; 59(6):3598-601.
    View in: PubMed
    Score: 0.525
  4. Iniguez E, S?nchez A, Vasquez MA, Mart?nez A, Olivas J, Sattler A, S?nchez-Delgado RA, Maldonado RA. Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells. J Biol Inorg Chem. 2013 Oct; 18(7):779-90.
    View in: PubMed
    Score: 0.468
  5. Lara D, Feng Y, Bader J, Savage PB, Maldonado RA. Anti-trypanosomatid activity of ceragenins. J Parasitol. 2010 Jun; 96(3):638-42.
    View in: PubMed
    Score: 0.376
  6. Iniguez E, Varela-Ramirez A, Mart?nez A, Torres CL, S?nchez-Delgado RA, Maldonado RA. Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis. Acta Trop. 2016 Dec; 164:402-410.
    View in: PubMed
    Score: 0.146
  7. Iniguez EA, Perez A, Maldonado RA, Skouta R. Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major. Bioorg Med Chem Lett. 2015 Nov 15; 25(22):5315-20.
    View in: PubMed
    Score: 0.136
  8. Mart?nez A, Carreon T, Iniguez E, Anzellotti A, S?nchez A, Tyan M, Sattler A, Herrera L, Maldonado RA, S?nchez-Delgado RA. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells. J Med Chem. 2012 Apr 26; 55(8):3867-77.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support